Substance Use Disorders

Faculty

Judy Chang, MD, MPH

Dr. Chang has been using a variety of qualitative approaches to understand various aspects of substance use disorders including prenatal use of tobacco, opioids, or marijuana. 

Jason Colditz, PhD, MEd

Prior to recently becoming faculty in the division of General Internal Medicine, Dr. Colditz was a research coordinator for over a decade. He also coordinated the Bridging Connections in Addiction Research (BCAR) initiative to foster interdisciplinary research around substance use, addiction, and recovery.

Walid F. Gellad, MD, MPH

Director, Center for Pharmaceutical Policy and Prescribing

Dr. Gellad's research focuses on physician prescribing practices and on policy issues affecting access and adherence to medications for patients. He has studied opioid use in the veteran population, specifically those receiving care from multiple health systems.

Raagini Jawa, MD, MPH, FASAM

Dr. Jawa is board certified in Internal Medicine, Infectious Disease, and Addiction Medicine. her research interests focus on the intersection of infectious disease and addiction, including studying how to optimize integration of harm reduction services for individuals with substance use disorders within traditional health settings.

Paul J. Joudrey, MD, MPH

Dr. Joudrey provides primary care, addiction medicine, and harm reduction services. His research focuses on identifying factors impacting addiction treatment access and outcomes across urban and rural communities and developing, evaluating, and scaling interventions tailored to community needs to improve the health of people who use drugs.

Tamar Krishnamurti, PhD

Dr. Krishnamurti is a PhD-trained behavioral scientist. Her research develops processes, (digital) tools, and communication strategies, grounded in psychological theory, to support informed decision making. Dr. Krishnamurti's work is highly interdisciplinary. She works closely with experts across the fields of psychology, medicine, computer science, engineering, and public health. While she primarily focuses on health in pregnancy and the postpartum period among US populations, she does work, both domestically and internationally, in areas ranging from addiction to climate change.

Jane Liebschutz, MD, MPH, FACP

Dr. Liebschutz’s research is focused on developing interventions to combat the current crisis in opioid use disorders. More broadly, her research focuses on substance use, violence, and mental health within the practice of general medical care.

Jessica S. Merlin, MD, PhD, MBA

Director, Challenges in Managing and Preventing Pain Clinical Research Center

Dr. Merlin's research focuses on chronic pain in people living with HIV (PLWH), and more generally, individuals with comorbid mental illness and addiction. Her studies range from pathogenesis to clinical epidemiology to behavioral interventions.

Payel Jhoom Roy, MD, MSc

Clinical Director, Addiction Medicine Consult Service

Dr. Roy is an Internal Medicine- and Addiction Medicine-trained physician and health services researcher. Her interests are in addressing barriers to accessing medications for opioid use disorder and in developing and expanding the addiction medicine workforce.

Bryant Shuey, MD, MPH

Dr. Shuey is a board-certified internist and health services researcher whose work focuses on substance use and chronic disease, with an emphasis on evaluating policies affecting treatment access for opioid use disorder.